Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1,468 out of 105,998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 304,085 | 259,278 |
| Total Cites | 4,166 | 5,823 |
| H-index | 31 | 38 |
| Hm-index | 12 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 334 | 501 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 1,823 | 2,230 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,007 | 3,423 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.70 |
| Self-Citation Percentage |
28.46%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1,367 out of 99,369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 289,037 | 253,660 |
| Total Cites | 4,012 | 5,643 |
| H-index | 31 | 37 |
| Hm-index | 12 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 327 | 494 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 1,782 | 2,189 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,878 | 3,281 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.72 |
| Self-Citation Percentage |
28.90%
|
|
Camarasa, María José
CSIC - Instituto de Quimíca Médica (IQM),
Spain
2022 Rank: 292,349
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1,386 out of 94,672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 292,349 | 254,568 |
| Total Cites | 3,716 | 5,310 |
| H-index | 30 | 35 |
| Hm-index | 12 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 257 | 424 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 1,662 | 2,067 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2,649 | 3,034 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.75 |
| Self-Citation Percentage |
30.02%
|
|
Camarasa, María José
CSIC - Instituto de Quimíca Médica (IQM),
Spain
2021 Rank: 304,650
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1,472 out of 88,725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 304,650 | 259,259 |
| Total Cites | 3,590 | 5,154 |
| H-index | 29 | 35 |
| Hm-index | 12 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 248 | 415 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 1,612 | 2,013 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2,564 | 2,944 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.75 |
| Self-Citation Percentage |
30.35%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.